2 small-cap biotech stocks that look like acquisition targets for Big Pharma

A seven-factor model across 52 biotechs flags Legend Biotech and Janux Therapeutics as top takeout candidates, both below half their consensus targets as a decade-defining patent cliff forces Big Pharma to buy growth.6